Skip to main content
Premium Trial:

Request an Annual Quote

Chris Hodkinson, Marc van der Schee, and Hamilton Scanlon

Owlstone Medical has appointed Chris Hodkinson as vice president of business development, Marc van der Schee as lead clinical research scientist, and Hamilton Scanlon as vice president of manufacturing. Hodkinson joins Owlstone from Abcodia, which he co-founded and where he served as director and chief operating officer. Van der Schee joins the company with 10 years of experience in the field of volatile biomarker research. Scanlon joins Owlstone with over 30 years of experience in product development. He has worked at start-up companies and PLCs, and has been responsible for setting up manufacturing facilities within China, Italy, and the UK.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.